EFFECT OF INHALED BECLOMETHASONE DIPROPIONATE IN YOUNGER CHILDREN WITH BRONCHIAL ASTHMA

DOI

Bibliographic Information

Other Title
  • 小児気管支喘息におけるベクロメタゾン吸入療法の検討
  • スペーサーを用いた低年齢児に対する検討

Search this article

Description

The effect of inhaled beclomethasone dipropionate (BDP) using the spaser (InspirEase) was studied in 24 children (aged three to six years) with moderate to severe bronchial asthma. Seventeen patients were receiving BDP for six weeks after control 2 weeks and seven control subjects were receiving no corticosteroid therapy.<br>1) Frequency of minor attack of bronchial asthma was decreased within two weeks after this therapy started, especially in children receiving 300μg/day of BDP.<br>2) Peak flow rate was increased within first two weeks in many cases.<br>3) Serum cortisol levels were decreased in some cases. Oral candidiasis was not observed in any patients. These data suggested that BDI therapy using the spacer was effective on control of moderate to severe childhood asthma.

Journal

Keywords

Details 詳細情報について

  • CRID
    1390001204475843456
  • NII Article ID
    130004370915
  • DOI
    10.3388/jspaci.8.52
  • ISSN
    18822738
    09142649
  • Data Source
    • JaLC
    • Crossref
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top